Church & Dwight (CHD) Stock Forecast: What Could Drive It in 2026
Last updated July 2026
Short answer
What is actually driving Church & Dwight (CHD) right now is Power-brand and personal-care mix: A concentrated set of power brands (Arm & Hammer, OxiClean, Trojan, Batiste, TheraBreath, Waterpik, Hero Cosmetics) generates most of the revenue, and the faster-growing personal-care names give CHD a higher-growth tilt than a pure household-products company. Revenue (TTM) is ~$6.2B. If that keeps playing out, the setup is favourable; the risk to it is u.S. No one can predict where CHD trades, and Walnut does not publish targets, so treat this as a scenario, not a price target or prediction.
What could drive Church & Dwight (CHD) higher?
1. Power-brand and personal-care mix
A concentrated set of power brands (Arm & Hammer, OxiClean, Trojan, Batiste, TheraBreath, Waterpik, Hero Cosmetics) generates most of the revenue, and the faster-growing personal-care names give CHD a higher-growth tilt than a pure household-products company. Continued innovation, notably around TheraBreath toothpaste, is central to the 2026 growth story.
2. Margin expansion and productivity
Adjusted gross margin expanded about 130 basis points to roughly 46.4% in Q1 2026 as productivity programs, acquisitions and favorable FX more than offset inflation and tariff costs. Sustained gross-margin gains are a key lever for the 5% to 8% adjusted EPS growth the company targets for 2026.
3. Cash generation and shareholder returns
CHD guides to roughly $1.15 billion of free cash flow in 2026, funding a long-running dividend (a dividend aristocrat with decades of increases) plus buybacks and bolt-on acquisitions. The forward dividend is about $1.23 per share for a yield near 1.3%.
4. Bolt-on M&A engine
Acquisitions like Waterpik, TheraBreath, Hero Cosmetics and Touchland have historically refreshed the portfolio toward higher-growth categories. Continued disciplined dealmaking is part of how management aims to offset slower legacy-brand growth.
What could weigh on CHD?
U.S. organic growth has been soft, with some domestic categories declining, so 2026 guidance is back-half weighted and carries execution risk on new-product launches. At around 30x trailing earnings, the valuation is a premium to the household-products group and leaves little margin for error if volumes or margins disappoint. The company competes with far larger rivals such as Procter & Gamble and Colgate-Palmolive that have bigger marketing budgets and shelf presence. Input-cost inflation, tariffs and private-label competition can pressure margins, and CHD faces routine product-related consumer litigation typical of large CPG companies. A separate SEC proxy-disclosure matter involving a former CEO was settled in 2024 and is not an active securities-fraud case.
Where CHD trades today
A forecast starts from where the stock actually is. These are CHD's current figures, not a projection: the drivers and risks above are what would move them.
Snapshot for CHD as of July 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.
How to think about a CHD forecast
Rather than chasing a price target, it tends to help to weigh the drivers above against the risks, decide how long you are willing to hold, and size the position so a wrong call is survivable. A “forecast” is really a probability-weighted view of those drivers playing out, not a number.
For the full picture, see the CHD guide and whether CHD is a buy. In Walnut you can pressure-test the thesis against your real portfolio.
The bottom line on the CHD outlook
The bottom line: what is driving Church & Dwight (CHD) is Power-brand and personal-care mix, with revenue (ttm) at ~$6.2B. If that keeps playing out the setup is favourable; the risk is u.S. No one can predict the price, so treat any CHD forecast as a scenario, not a target or prediction, and decide from your own thesis and time horizon. Walnut is not an investment adviser.
More on CHD
- CHD stock guide (what the company does, ETFs that hold it, similar stocks, and the themes it fits)
- Is CHD a buy? (the case for, the risks, and a framework to decide)
- Does CHD pay a dividend?
Build a basket around CHD with Walnut
Use Church & Dwight as one constituent in a thematic basket Walnut's AI helps you assemble. Describe a thesis you believe in, the AI proposes the holdings and weights, and you approve before any broker order.
FAQ
What is the forecast for Church & Dwight (CHD)?
+
No one can reliably predict where CHD will trade, and Walnut does not publish price targets. What is more useful is the setup: the drivers that could push Church & Dwight higher and the risks that could weigh on it. This page lays out both so you can form your own view. Not a recommendation.
What could drive CHD higher?
+
The main growth drivers are Power-brand and personal-care mix; Margin expansion and productivity; Cash generation and shareholder returns. Whether they play out is the real question, not a guaranteed path.
What are the risks to CHD?
+
U.S. organic growth has been soft, with some domestic categories declining, so 2026 guidance is back-half weighted and carries execution risk on new-product launches. At around 30x trailing earnings, the valuation is a premium to the household-products group and leaves little margin for error if volumes or margins disappoint. The company competes with far larger rivals such as Procter & Gamble and Colgate-Palmolive that have bigger marketing budgets and shelf presence. Input-cost inflation, tariffs and private-label competition can pressure margins, and CHD faces routine product-related consumer litigation typical of large CPG companies. A separate SEC proxy-disclosure matter involving a former CEO was settled in 2024 and is not an active securities-fraud case.
Will CHD stock go up in 2026?
+
Nobody knows, and anyone who says they do is guessing. Church & Dwight's direction depends on whether the drivers above outweigh the risks, plus the broader market. Focus on the thesis and your time horizon rather than a single-year call.
Is CHD a buy?
+
That depends on your thesis, time horizon, and what you already own, not on a forecast. See the CHD "is it a buy?" page for a framework. Walnut is not an investment adviser.
How did CHD perform in early 2026?
+
First-quarter 2026 net sales were about $1.47 billion, up 0.2%, with organic sales up 5.0% and adjusted EPS of $0.95. Both revenue and earnings came in ahead of the company's own outlook.
Walnut is informational, not investment advice. This page describes drivers and risks; it is not a price forecast, target, or recommendation. Markets are uncertain and past performance does not predict future results.